| Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer (NCT05438927) | H. Lee Moffitt Cancer Center and Research Institute | 2022-07-15 |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors (NCT06245330) | Ascentawits Pharmaceuticals, Ltd | 2022-07-07 |
| Project CADENCE (CAncer Detected Early caN be CurEd) (NCT05633342) | MiRXES Pte Ltd | 2022-07-07 |
| A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma (NCT05336266) | Andrew Hendifar, MD | 2022-07-01 |
| The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma (NCT06378580) | Luo Cong | 2022-07-01 |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer (NCT05451849) | TCR2 Therapeutics | 2022-06-21 |
| Is One Pass Enough for the Diagnosis of the Pancreatic Masses During EUS-FNB? (NCT05436704) | Istituto Clinico Humanitas Mater Domini | 2022-06-21 |
| A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers (NCT05360680) | Cue Biopharma | 2022-06-14 |
| GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites (NCT05438459) | Kyushu University | 2022-06-08 |
| Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors (NCT05538195) | Chongqing Precision Biotech Co., Ltd | 2022-06-07 |
| Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT (NCT05430841) | The First Affiliated Hospital of Xiamen University | 2022-06-01 |
| 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer (NCT05875753) | Peking Union Medical College Hospital | 2022-06-01 |
| Adavosertib and Gemcitabine in Advanced Pancreatic (NCT05212025) | James Cleary, MD, PhD | 2022-06-01 |
| EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients (NCT05188573) | ClearNote Health | 2022-06-01 |
| Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients (NCT05369312) | Betta Pharmaceuticals Co., Ltd. | 2022-06-01 |
| FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT05395052) | Fate Therapeutics | 2022-05-31 |
| ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer (NCT05355298) | Amplia Therapeutics Limited | 2022-05-31 |
| Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients (NCT05411133) | Arbele Pty Ltd | 2022-05-30 |
| Role of Exosomes in Pancreatic Cancer Progression (NCT06777030) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2022-05-22 |
| NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer (NCT06094140) | Australasian Gastro-Intestinal Trials Group | 2022-05-20 |
| Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping (NCT06048458) | University College, London | 2022-05-18 |
| EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients (NCT05247164) | IRCCS San Raffaele | 2022-05-17 |
| Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer (NCT04469504) | University Hospital, Lille | 2022-05-17 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors (NCT05311618) | NGM Biopharmaceuticals, Inc | 2022-05-11 |
| Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study (NCT06404840) | Tianjin Medical University Cancer Institute and Hospital | 2022-05-06 |
| Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma (NCT05141513) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-05-06 |
| Porto-Venous Radiomics in Pancreatic Cancer (NCT05700110) | Royal Marsden NHS Foundation Trust | 2022-05-05 |
| cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (NCT05366881) | Adela, Inc | 2022-05-03 |
| Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors (NCT07121829) | Day One Biopharmaceuticals, Inc. | 2022-05-02 |
| Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) (NCT05044065) | Karolinska Institutet | 2022-05-01 |
| Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy (NCT05251233) | Washington University School of Medicine | 2022-04-21 |
| Michigan Genetic Hereditary Testing (MiGHT) (NCT05162846) | University of Michigan Rogel Cancer Center | 2022-04-21 |
| MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors (NCT05076760) | Memgen, Inc. | 2022-04-21 |
| A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors (NCT05070247) | Takeda | 2022-04-14 |
| An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC (NCT05327582) | Chinese PLA General Hospital | 2022-04-12 |
| Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer (NCT05013216) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-04-11 |
| Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion. (NCT05271344) | Centre Hospitalier Universitaire de Liege | 2022-04-08 |
| Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors (NCT05194735) | Alaunos Therapeutics | 2022-04-04 |
| Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques (NCT05289895) | The Affiliated Hospital of Qingdao University | 2022-04-01 |
| Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma (NCT05525286) | SOTIO Biotech a.s. | 2022-03-31 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies (NCT05462314) | Viome | 2022-03-29 |
| Combined Exercise and Nutritional Intervention in GI Cancer Patients (NCT05420259) | Hospital Beatriz Ângelo | 2022-03-21 |
| Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors (NCT05169437) | Tempus AI | 2022-03-15 |
| Radiology Registry on Pancreatic Malignancies (NCT05714111) | IRCCS San Raffaele | 2022-03-04 |
| huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer (NCT05057715) | University of Pennsylvania | 2022-03-02 |
| A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China (NCT05638269) | Zhujiang Hospital | 2022-03-01 |
| Effectiveness of Auricular Point Acupressure in Improving Quality of Life in Patients With Pancreatic Cancer (NCT05139199) | Taipei Veterans General Hospital, Taiwan | 2022-02-23 |
| Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma (NCT05275062) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2022-02-15 |
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer (NCT05178628) | Michalis Karamouzis | 2022-02-10 |
| DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer (NCT05604573) | Seoul National University Hospital | 2022-02-09 |
| Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer (NCT03958019) | University of Dublin, Trinity College | 2022-01-25 |
| Resilience and Equity in Aging, Cancer, and Health (REACH) (NCT04674267) | Dana-Farber Cancer Institute | 2022-01-18 |
| Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors (NCT04683939) | BioNTech SE | 2022-01-18 |
| Registry for Advanced Endoscopy (NCT05187312) | Region Stockholm | 2022-01-14 |
| Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer (NCT05596370) | Seoul National University Hospital | 2022-01-06 |
| Cabozantinib and Pembrolizumab in Metastatic Pancreas (NCT05052723) | Joseph Kim | 2022-01-04 |
| SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer (NCT05185869) | Ruijin Hospital | 2022-01-01 |
| Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer (NCT05729737) | Peking Union Medical College Hospital | 2022-01-01 |
| LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery (NCT04105062) | Washington University School of Medicine | 2021-12-31 |
| Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver (NCT05182112) | Memorial Sloan Kettering Cancer Center | 2021-12-20 |
| MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC (NCT05114213) | Ludwig-Maximilians - University of Munich | 2021-12-15 |
| Intraoperative Endoscopic Ultrasound for Pancreatic Cancer (NCT04899739) | IHU Strasbourg | 2021-12-05 |
| Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. (NCT05102110) | Origin Sciences | 2021-12-01 |
| Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer (NCT05083780) | Changhoon Yoo | 2021-11-30 |
| Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan (NCT05147168) | Taipei Veterans General Hospital, Taiwan | 2021-11-22 |
| Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer (NCT05141643) | Memorial Sloan Kettering Cancer Center | 2021-11-18 |
| Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients (NCT04751435) | Memorial Sloan Kettering Cancer Center | 2021-11-16 |
| A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours (NCT05057013) | Cancer Research UK | 2021-11-10 |
| Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. (NCT05116917) | Herlev Hospital | 2021-11-05 |
| Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan (NCT05005403) | AbbVie | 2021-11-01 |
| EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma. (NCT05131776) | Chinese University of Hong Kong | 2021-11-01 |
| Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (NCT04981119) | A2 Biotherapeutics Inc. | 2021-10-29 |
| CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma (NCT05052567) | Qilu Pharmaceutical Co., Ltd. | 2021-10-21 |
| Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer (NCT04146298) | Changhai Hospital | 2021-10-21 |
| Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer (NCT04820179) | University of Arizona | 2021-10-12 |
| Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas (NCT04617457) | University of Cologne | 2021-10-10 |
| Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma (NCT04862260) | CHU de Quebec-Universite Laval | 2021-10-04 |
| Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor (NCT05009966) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-09-16 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors (NCT05415475) | Chongqing Precision Biotech Co., Ltd | 2021-09-10 |
| TCR-T Cells in the Treatment of Advanced Pancreatic Cancer (NCT06054984) | Ruijin Hospital | 2021-09-07 |
| Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer (NCT04927780) | Erasmus Medical Center | 2021-09-07 |
| The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients (NCT05168527) | Fudan University | 2021-09-03 |
| Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry (NCT05010226) | National Taiwan University Hospital | 2021-09-01 |
| Preoperative Biliary Drainage in Malignant Biliary Obstruction (NCT04847297) | University of Pecs | 2021-09-01 |
| Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study (NCT05223218) | Namida Lab | 2021-08-25 |
| Investigator-initiated Clinical Trial of MIKE-1 (NCT05064618) | Nagoya University | 2021-08-23 |
| ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing (NCT05380557) | Invitae Corporation | 2021-08-23 |
| Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer (NCT05043532) | Orlando Health, Inc. | 2021-08-18 |
| Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) (NCT04611867) | Inna Chen, MD | 2021-08-17 |
| Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients (NCT04536077) | Washington University School of Medicine | 2021-08-13 |
| MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients (NCT04600154) | National Taiwan University Hospital | 2021-08-10 |
| Correlation Between Complications After Pancreaticoduodenectomy and Microbiota (NCT04931069) | University Hospital, Toulouse | 2021-08-06 |
| Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan (NCT04984174) | National Cancer Center, Korea | 2021-08-04 |
| Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer (NCT04966143) | Shanghai Longyao Biotechnology Inc., Ltd. | 2021-08-01 |
| Pancreatic Cancer and Oral Microbiome (NCT04993846) | Azienda Ospedaliera Universitaria Integrata Verona | 2021-07-26 |
| Pancreatic Cancer Evolution Upon Treatment (NCT05195281) | IRCCS San Raffaele | 2021-07-14 |
| A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors (NCT04801095) | Wellmarker Bio | 2021-07-14 |